Stay updated on Safety of Growth Hormone-Deficiency Treatment Clinical Trial
Sign up to get notified when there's something new on the Safety of Growth Hormone-Deficiency Treatment Clinical Trial page.

Latest updates to the Safety of Growth Hormone-Deficiency Treatment Clinical Trial page
- ChecktodayChange DetectedRevision updated from v3.3.3 to v3.3.4 in the page header — No study data or content has changed, and the update is limited to metadata. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedAdded a consolidated Locations section listing study sites by state (California, Colorado, Delaware, Florida, Michigan, Nevada, New York, North Carolina, Pennsylvania, Texas, Virginia, Washington) with a revision tag v3.3.3. The HHS Vulnerability Disclosure link was removed.SummaryDifference1%

- Check51 days agoChange DetectedRevision label updated to v3.3.2 (previously v3.2.0). This is a minor maintenance update with no changes to the study content.SummaryDifference0.0%

- Check58 days agoChange DetectedThe government funding/operating status warning has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check72 days agoChange DetectedNo significant changes detected in the page content; the study details and related information appear the same across screenshots.SummaryDifference0.3%

- Check101 days agoChange DetectedUpdated the page to v3.2.0 with a prominent notice about potential data/tansaction delays due to funding gaps and where to check operating status; previous v3.1.0 reference removed.SummaryDifference4%

Stay in the know with updates to Safety of Growth Hormone-Deficiency Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Growth Hormone-Deficiency Treatment Clinical Trial page.